Artestatin
On sale on the US market (according to the DSLD)
Health Concerns, food supplement from the US market
Artestatin (Health Concerns), a food supplement au code-barres 810034440044, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034440044
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Herbal Blend | Blend | 650 mg |
| Chinese Wormwood Herb Extract | Plant | not stated |
| Cascara Sagrada (Frangula purshiana) | Plant | not stated |
| Java Brucea Fruit Extract (Brucea javanica) | Plant | not stated |
| Chamomile flower extract | Plant | not stated |
| Magnolia Bark Extract | Plant | not stated |
| Pinellia rhizome extract (Pinellia ternata) | Plant | not stated |
| Eleuthero root extract (Eleutherococcus senticosus) | Plant | not stated |
| Milk Thistle seed extract (Silybum marianum) | Plant | not stated |
| Tangerine Peel Extract | Plant | not stated |
| Codonopsis root extract (Codonopsis pilosula) | Plant | not stated |
| Licorice root extract | Plant | not stated |
| Coptis extract | Plant | not stated |
| Ginger extract | Plant | not stated |
| Cang-zhu Atractylodes | Plant | not stated |
| Cardamom extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Artestatin
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : Artemesia anua concentrate (quantity not stated)
- Active ingredient added : Brucea (quantity not stated)
- Active ingredient added : Cardamon (quantity not stated)
- Active ingredient added : Citrus (quantity not stated)
- Active ingredient added : Codonopsis (quantity not stated)
- Active ingredient added : Coptis (quantity not stated)
- Active ingredient added : Dichroa (quantity not stated)
- Active ingredient added : Dolichos (quantity not stated)
- Active ingredient added : Ginger (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Magnolia (quantity not stated)
- Active ingredient added : Pinella (quantity not stated)
- Active ingredient added : Pogostemon (quantity not stated)
- Active ingredient added : Proprietary Blend (750 mg)
- Active ingredient added : Pulsatilla (quantity not stated)
- Active ingredient added : Red Atractylodes (quantity not stated)
- Active ingredient removed : Cang-zhu Atractylodes (quantity not stated)
- Active ingredient removed : Cardamom extract (quantity not stated)
- Active ingredient removed : Cascara Sagrada (quantity not stated)
- Active ingredient removed : Chamomile flower extract (quantity not stated)
- Active ingredient removed : Chinese Wormwood Herb Extract (quantity not stated)
- Active ingredient removed : Codonopsis root extract (quantity not stated)
- Active ingredient removed : Coptis extract (quantity not stated)
- Active ingredient removed : Eleuthero root extract (quantity not stated)
- Active ingredient removed : Ginger extract (quantity not stated)
- Active ingredient removed : Java Brucea Fruit Extract (quantity not stated)
- Active ingredient removed : Licorice root extract (quantity not stated)
- Active ingredient removed : Magnolia Bark Extract (quantity not stated)
- Active ingredient removed : Milk Thistle seed extract (quantity not stated)
- Active ingredient removed : Pinellia rhizome extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (650 mg)
- Active ingredient removed : Tangerine Peel Extract (quantity not stated)
Official label: Artestatin
Entered into DSLD on 23 August 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Artemesia anua concentrate (quantity not stated)
- Active ingredient added : Brucea (quantity not stated)
- Active ingredient added : Cardamon (quantity not stated)
- Active ingredient added : Citrus (quantity not stated)
- Active ingredient added : Codonopsis (quantity not stated)
- Active ingredient added : Coptis (quantity not stated)
- Active ingredient added : Dichroa (quantity not stated)
- Active ingredient added : Dolichos (quantity not stated)
- Active ingredient added : Ginger (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Magnolia (quantity not stated)
- Active ingredient added : Pinellia (quantity not stated)
- Active ingredient added : Pogostemon (quantity not stated)
- Active ingredient added : Proprietary Blend (Herb/Botanical) (2,250 mg)
- Active ingredient added : Pulsatilla (quantity not stated)
- Active ingredient added : Red Atractylodes (quantity not stated)
- Active ingredient removed : Cang-zhu Atractylodes (quantity not stated)
- Active ingredient removed : Cardamom extract (quantity not stated)
- Active ingredient removed : Cascara Sagrada (quantity not stated)
- Active ingredient removed : Chamomile flower extract (quantity not stated)
- Active ingredient removed : Chinese Wormwood Herb Extract (quantity not stated)
- Active ingredient removed : Codonopsis root extract (quantity not stated)
- Active ingredient removed : Coptis extract (quantity not stated)
- Active ingredient removed : Eleuthero root extract (quantity not stated)
- Active ingredient removed : Ginger extract (quantity not stated)
- Active ingredient removed : Java Brucea Fruit Extract (quantity not stated)
- Active ingredient removed : Licorice root extract (quantity not stated)
- Active ingredient removed : Magnolia Bark Extract (quantity not stated)
- Active ingredient removed : Milk Thistle seed extract (quantity not stated)
- Active ingredient removed : Pinellia rhizome extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (650 mg)
- Active ingredient removed : Tangerine Peel Extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cascara Sagrada
Read the warning, when it applies and the studies cited
CASCARA SAGRADA - FRANGULA PURSHIANA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2020; Brinker 2010; WHO 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2020; Brinker 2010; WHO 2002; Blumenthal et al. 2000).
Sources cited by Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2020; Brinker 2010; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2020; Brinker 2010; WHO 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Known adverse reactions
Stop use if hypersensitivity/allergy or diarrhea occurs (EMA 2020; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- Eleuthero root extract
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Milk Thistle seed extract
Read the warning, when it applies and the studies cited
MILK THISTLE - SILYBUM MARIANUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).
Sources cited by Health Canada (2)
- Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
- Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Artestatin (Health Concerns): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/810034440044-artestatin-health-concerns, updated 22 January 2022.